The Lancet's COVID-19 Resource Centre: Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa and more

New COVID-19 Content is Now Available

Dear Victor Norberto,

New this week: Substantial progress has been made in reducing the burden of malaria in Africa since 2000, but those gains could be jeopardised if the COVID-19 pandemic affects the availability of key malaria control interventions. Compared with the responses to COVID-19 in high-income nations, the measures taken in Africa come amid the backdrop of more acute health-system resource limitations and persistently higher morbidity and mortality from other infectious diseases. As such, on top of concerns about malaria itself, alarm is growing about the broader health, economic, and societal effects of the measures imposed to slow the spread of COVID-19. Of particular concern is the possible disruption to efforts to control other endemic diseases that pose ongoing threats. An Article published in The Lancet Infectious Diseases aims to evaluate plausible effects on malaria incidence and mortality under different levels of disruption to malaria control. Read the Article here.

We hope you find the Resource Centre on COVID-19 to be informative. 

We want to make sure that you receive information that is interesting and relevant to you, so if you prefer to receive updates to include new Chinese translations please click here.

Yours sincerely,

The Lancet

NEW content on COVID-19

The Lancet What can we expect from first-generation COVID-19 vaccines? Safety and efficacy of the Russian COVID-19 vaccine: more information needed Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply The Lancet Child & Adolescent Health A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process COVID-19 public health measures and respiratory syncytial virus The Lancet Digital Health Artificial intelligence in COVID-19 drug repurposing Open Access The Lancet Gastroenterology & Hepatology SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19 Open Access COVID-19 vaccinations in patients with inflammatory bowel disease The Lancet Infectious Diseases Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis Open Access COVID-19 in malaria-endemic regions: potential consequences for malaria intervention coverage, morbidity, and mortality Open Access The Lancet Public Health Evaluation of the COVID-19 response in Spain: principles and requirements Open Access Building resilient societies after COVID-19: the case for investing in maternal, neonatal, and child health Open Access The Lancet Respiratory Medicine The UCL Ventura CPAP device for COVID-19 The Lancet Rheumatology Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study The contribution of the observational research design to COVID-19 research EClinicalMedicine An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19 Open Access The characteristics of COVID-19 transmission from case to high-risk contact, a statistical analysis from contact tracing data Open Access Towards characterized convalescent plasma for COVID-19: The dose matters Open Access